🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This is a prospective, multicenter, Phase Ib clinical study designed to eva...
Status
Enrolling By Invitation
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2026-01-01
Trial ID
NCT07353294
Treatments Being Tested
This study aims to determine whether morning versus afternoon treatment imp...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-12-02
Trial ID
NCT07224971
Treatments Being Tested
This study will evaluate safety, pharmacodynamics and biomarkers of subcuta...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2023-04-03
Trial ID
NCT05704985
Treatments Being Tested
Immune checkpoint inhibitors (ICIs) have transformed the treatment of solid...
Status
Recruiting
Location
First Affiliated Hospital of Fujian Medical University
Start Date
2019-01-10
Trial ID
NCT07357636
The purpose of this study is to evaluate the safety of sequential intratumo...
Status
Completed
Location
Chevy Chase RCCA
Start Date
2015-03
Trial ID
NCT02423863
Treatments Being Tested
A single-arm, interventional study combining Immunotherapy and propranolol ...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2023-07-05
Trial ID
NCT05451043
Treatments Being Tested
Single arm, set dose clinical trial of Lamivudine for Relapsed Refractory S...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2024-09-26
Trial ID
NCT06494579
Treatments Being Tested